Carlos Mario Muñetón Peña
University of Antioquia
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Carlos Mario Muñetón Peña.
International Journal of Cancer | 2018
Carlos Vaccaro; Francisco López-Kostner; Adriana Della Valle; Edenir Inêz Palmero; Benedito Mauro Rossi; Marina Antelo; Angela Solano; Dirce Maria Carraro; Nora Manoukian Forones; Mabel Bohorquez; Leonardo S Lino-Silva; Jose Buleje; Florencia Spirandelli; Kiyoko Abe-Sandes; Ivana Nascimento; Yasser Sullcahuaman; Carlos Sarroca; María L. Gonzalez; Alberto Ignacio Herrando; Karin Alvarez; Florencia Neffa; Henrique Campos reis Galvão; Patricia Esperon; Mariano Golubicki; Daniel Cisterna; Florencia C. Cardoso; Giovana Tardin Torrezan; Samuel Aguiar Junior; Célia Aparecida Marques Pimenta; Maria Nirvana da Cruz Formiga
Colorectal cancer (CRC) is one of the most common cancers in Latin America and the Caribbean, with the highest rates reported for Uruguay, Brazil and Argentina. We provide a global snapshot of the CRC patterns, how screening is performed, and compared/contrasted to the genetic profile of Lynch syndrome (LS) in the region. From the literature, we find that only nine (20%) of the Latin America and the Caribbean countries have developed guidelines for early detection of CRC, and also with a low adherence. We describe a genetic profile of LS, including a total of 2,685 suspected families, where confirmed LS ranged from 8% in Uruguay and Argentina to 60% in Peru. Among confirmed LS, path_MLH1 variants were most commonly identified in Peru (82%), Mexico (80%), Chile (60%), and path_MSH2/EPCAM variants were most frequently identified in Colombia (80%) and Argentina (47%). Path_MSH6 and path_PMS2 variants were less common, but they showed important presence in Brazil (15%) and Chile (10%), respectively. Important differences exist at identifying LS families in Latin American countries, where the spectrum of path_MLH1 and path_MSH2 variants are those most frequently identified. Our findings have an impact on the evaluation of the patients and their relatives at risk for LS, derived from the gene affected. Although the awareness of hereditary cancer and genetic testing has improved in the last decade, it is remains deficient, with 39%–80% of the families not being identified for LS among those who actually met both the clinical criteria for LS and showed MMR deficiency.
Revista Colombiana de Gastroenterologia | 2008
Gloria Ramírez Gaviria; Juan Carlos Herrera Patiño; Carlos Mario Muñetón Peña; Juan Ricardo Márquez Velásquez; Luís Fernando Isaza Jiménez
Rev. Univ. Ind. Santander, Salud | 2004
Juan Carlos Herrera Patiño; Gonzalo Vásquez Palacio; José Luis Ramírez Castro; Carlos Mario Muñetón Peña
Iatreia | 2008
Juan Carlos Herrera Patiño; Gloria Ramírez Gaviria; Carlos Mario Muñetón Peña
Iatreia | 2012
Katherine Andrea Palacio Rúa; Carlos Mario Muñetón Peña
Iatreia | 2002
Carlos Mario Muñetón Peña; José Luis Ramírez Castro
Iatreia | 1998
José Luis Ramírez Castro; Carlos Mario Muñetón Peña; Gonzalo Vásquez Palacio; Bernardo Agudelo Jaramillo
Revista Colombiana de Gastroenterología | 2018
Carlos Humberto Afanador Ayala; Carlos Mario Muñetón Peña
Revista Colombiana de Cancerología | 2017
Carlos Humberto Afanador Ayala; Katherine Andrea Palacio Rúa; Luís Fernando Isaza Jiménez; Enoc Ahumada Rodríguez; Carlos Mauricio Ocampo; Carlos Mario Muñetón Peña
Revista Colombiana de Cancerología | 2016
Laura María Medina Gómez; Gonzalo Vásquez Palacio; Carlos Mario Muñetón Peña